Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E7MB
|
||||
| Drug Name |
Dalteparin Sodium
|
||||
| Synonyms |
Fragmin; Fragmin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Hematology [ICD10:D50-D77] | Approved | [551871] | ||
| Company |
Pfizer Inc
|
||||
| Formula |
C12H17NO20S3-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Coagulation factor Xa | Target Info | Modulator | [556264] | |
| KEGG Pathway | Complement and coagulation cascades | ||||
| PANTHER Pathway | Blood coagulation | ||||
| Pathway Interaction Database | Beta2 integrin cell surface interactions | ||||
| PathWhiz Pathway | Coagulation | ||||
| Reactome | Extrinsic Pathway of Fibrin Clot Formation | ||||
| Intrinsic Pathway of Fibrin Clot Formation | |||||
| Common Pathway of Fibrin Clot Formation | |||||
| Gamma-carboxylation of protein precursors | |||||
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.